Abiopharma

Silo Pharma Notification (SILO)

Windtree Receives Offer for Its PreclinicalOncology Drug Candidate

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board

Avidity Biosciences to Present Topline Data from Phase 1/2 FORTITUDE™ Trial of Del-brax in People Living with Facioscapulohumeral Muscular Dystrophy at 32nd Annual FSHD Society International Research Congress

Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

Register Today! Nephros Analyst and Investor Virtual Event Reminder

Biogen Highlights the Potential of Felzartamab for a Range of Immune-Mediated Diseases Including Three Phase 3 Programs in Rare Kidney Diseases

Lisata Therapeutics to Present at the 2025 BIO International Convention

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing